Deucravacitinib treatment did not affect immune response to SARS-Cov-2 vaccines and infection in patients with plaque psoriasis: results from the Phase 3 POETYK long-term extension trial

Category Primary study
JournalBRITISH JOURNAL OF DERMATOLOGY
Year 2024
This article has no abstract
Epistemonikos ID: 846437cb02cdc79c70fbee2a6cca4bc7ff62c1e4
First added on: Jan 14, 2025